Influencing and shaping our sector BIA update: October 2023 - January 2024
The BioIndustry Association (BIA) continued to represent the innovative life science sector to Ministers and senior policymakers between October 2023 and January 2024. This quarterly report provides an overview of these engagements.
The Prime Minister's reshuffle in November presented a new ministerial team whom we can expect to take the Conservative Party into the next general election. Remaining at the Exchequer was Jeremy Hunt, whose Autumn Statement in November brought a raft of measures to support our sector, many of which the BIA has been advocating for years.
The BIA continued to set the policy agenda this quarter with new reports on genomics, rare disease treatments, and cell and gene therapies: three emerging sectors powered by UK innovation.
Never attached to our keyboards for long, we also made our influence felt at numerous events this quarter. From internal events like TechBio UK and bioProcess UK to meetings with the Office for Life Sciences, Intellectual Property Office, and MHRA, we at the BIA were out and about making the voice of the innovative life sciences heard.
We are in the process of reforming this report to ensure it is as useful as can be, so look out for some minor changes this quarter.
Read on for further details of all the BIA's important influencing work on behalf of the sector across our key policy areas.